Thermo Fisher Scientific (TMO) Non-Current Debt (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Non-Current Debt for 18 consecutive years, with $42.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt rose 20.7% year-over-year to $42.3 billion; the trailing twelve-month figure through Jun 2026 stood at $42.3 billion (up 20.7% YoY), and the FY2025 full-year result was $39.2 billion, up 26.07% from the prior year.
• Non-Current Debt fell to $42.3 billion in Q2 2026 per TMO's latest filing, from $42.9 billion in the prior quarter.
• Across five years, Non-Current Debt topped out at $42.9 billion in Q1 2026 and bottomed at $28.9 billion in Q4 2022.
• Historically, Non-Current Debt has averaged $35.0 billion across 5 years, with a median of $35.0 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Non-Current Debt surged 77.31% in 2022, then slipped 10.52% in 2024.
• Over 5 years, Non-Current Debt stood at $34.3 billion in 2022, then rose by 1.31% to $34.7 billion in 2023, then fell by 10.52% to $31.1 billion in 2024, then gained by 26.07% to $39.2 billion in 2025, then rose by 7.94% to $42.3 billion in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $42.3 billion, $42.9 billion, and $39.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.